<code id='97F10FDE6E'></code><style id='97F10FDE6E'></style>
    • <acronym id='97F10FDE6E'></acronym>
      <center id='97F10FDE6E'><center id='97F10FDE6E'><tfoot id='97F10FDE6E'></tfoot></center><abbr id='97F10FDE6E'><dir id='97F10FDE6E'><tfoot id='97F10FDE6E'></tfoot><noframes id='97F10FDE6E'>

    • <optgroup id='97F10FDE6E'><strike id='97F10FDE6E'><sup id='97F10FDE6E'></sup></strike><code id='97F10FDE6E'></code></optgroup>
        1. <b id='97F10FDE6E'><label id='97F10FDE6E'><select id='97F10FDE6E'><dt id='97F10FDE6E'><span id='97F10FDE6E'></span></dt></select></label></b><u id='97F10FDE6E'></u>
          <i id='97F10FDE6E'><strike id='97F10FDE6E'><tt id='97F10FDE6E'><pre id='97F10FDE6E'></pre></tt></strike></i>

          focus

          focus

          author:leisure time    Page View:2

          Which presentations are worth catching at ASCO this weekend? What is exon-skipping? And how do you pronounce bronchiectasis?

          This week on “The Readout LOUD,” we preview some of the research that will be presented at the American Society of Clinical Oncology conference in Chicago. We also discuss the latest news in the health and life sciences, including a milestone in lung disease R&D and a Duchenne muscular dystrophy confirmatory trial failure.  

          advertisement

          To read more about Merus’ combination therapy, go here; For more on Johnson & Johnson’s mixed data, click here; For more on Nippon Shinyaku’s Duchenne drug trial failure, go here; To read more on Insmed’s bronchiectasis treatment, click here; To sign up for STAT’s ASCO newsletter, click here.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          explore

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          Vir antibody drug aimed at influenza A fails in clinical trial
          Vir antibody drug aimed at influenza A fails in clinical trial

          F.A.Murphy/CDCVirBiotechnologysaidThursdaythatalong-actingantibodydrugdesignedtoprotecthealthyindivi

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          Inequities make cancer less preventable for women: report

          AdobePatriarchyisn’tawordthatOphiraGinsburgexpectedtobeatthecenterofherworkasacancerresearcherbut,li